Literature DB >> 21188468

The role of 99mTc-tetrofosmin brain SPECT in differentiating treatment-induced necrosis from recurrent brain tumor.

George A Alexiou, Andreas D Fotopoulos, Spyridon Tsiouris, Spyridon Voulgaris, Athanasios P Kyritsis.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21188468     DOI: 10.1007/s11060-010-0507-z

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


× No keyword cloud information.
  4 in total

Review 1.  Treatment induced necrosis versus recurrent/progressing brain tumor: going beyond the boundaries of conventional morphologic imaging.

Authors:  Rajan Jain; Jayant Narang; Pia M Sundgren; David Hearshen; Sona Saksena; Jack P Rock; Jorge Gutierrez; Tom Mikkelsen
Journal:  J Neurooncol       Date:  2010-02-24       Impact factor: 4.130

2.  Influence of glioma's multidrug resistance phenotype on (99m)Tc-tetrofosmin uptake.

Authors:  George A Alexiou; Anna Goussia; Athanasios P Kyritsis; Spyridon Tsiouris; Antigoni Ntoulia; Vassiliki Malamou-Mitsi; Spyridon Voulgaris; Andreas D Fotopoulos
Journal:  Mol Imaging Biol       Date:  2011-04       Impact factor: 3.488

3.  Characterization of intracranial space-occupying lesions by ⁹⁹(m)Tc-Tetrofosmin SPECT.

Authors:  Andreas D Fotopoulos; Athanasios P Kyritsis; Spyridon Tsiouris; Jihad Al-Boucharali; Athanasios Papadopoulos; Spyridon Voulgaris; George A Alexiou
Journal:  J Neurooncol       Date:  2010-05-23       Impact factor: 4.130

4.  Evaluation of brain tumor recurrence by (99m)Tc-tetrofosmin SPECT: a prospective pilot study.

Authors:  George A Alexiou; Andreas D Fotopoulos; Athanasios Papadopoulos; Athanasios P Kyritsis; Konstantinos S Polyzoidis; Spyridon Tsiouris
Journal:  Ann Nucl Med       Date:  2007-07-25       Impact factor: 2.668

  4 in total
  1 in total

1.  Results of a questionnaire regarding practice patterns for the diagnosis and treatment of intracranial radiation necrosis after SRS.

Authors:  Abigail L Stockham; Manmeet Ahluwalia; Chandana A Reddy; John H Suh; Aryavarta Kumar; Michael A Vogelbaum; Gene H Barnett; Erin S Murphy; Samuel T Chao
Journal:  J Neurooncol       Date:  2013-09-18       Impact factor: 4.130

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.